Skip to main content
. 2022 Apr 18;7(4):100969. doi: 10.1016/j.adro.2022.100969

Table 1.

Distribution and age of diagnosis of second primary CNS tumors by whether radiation was part of the primary malignancy treatment course

No. (%)
Age of second primary diagnosis, median (1st to 3rd quantile), y
No radiation Radiation P value No radiation Radiation P value
Overall 365 331 49 (30-65) 41 (30-54) 7.1e-5
Ependymoma 12 (3.3) 6 (1.8) .325 47 (28-64) 43.5 (37-46) 0.482
Medulloblastoma 7 (1.9) 6 (1.8) 1 21 (12-31) 28 (19-50) 0.295
Pilocytic astrocytoma 23 (6.3) 2 (0.6) 1.28e-4 20 (12-34) 30 (22-38) 0.581
Astrocytoma 35 (9.6) 21 (6.3) 0.152 49 (26-60) 34 (18-44) 0.054
Oligodendroglioma 33 (9.0) 17 (5.1) 0.065 39 (33-55) 48 (43-51) 0.412
Glioblastoma 53 (14.5) 68 (20.5) 0.046 63 (46-70) 45 (33-54) 1.55e-5
Other glioma 28 (7.7) 21 (6.3) 0.593 41 (24-54) 34 (21-44) 0.322
Lymphoma 4 (1.1) 2 (0.6) 82.5 (78-86) 55.5 (48-63) 0.133
Meningioma 88 (24.1) 142 (42.9) 2.19e-7 61 (48-75) 40.5 (29-53) 7.54e-13
Nerve sheath 27 (7.4) 14 (4.2) 0.107 40 (18-60) 38.5 (31-63) 0.492
Other histology 55 (15.1) 32 (9.7) 0.042 41 (21-58) 46 (37-59) 0.133

Abbreviation: CNS = central nervous system. Bold faced P-values indicate significance at P < .05.